- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr John Schorge Discusses Prevention Methods in Ovarian Cancer
John Schorge, MD, associate editor of The Green Journal, and Gynecologic Oncologist at Tufts Medical Center, discusses different prevention methods in ovarian cancer.
John Schorge, MD, associate editor of The Green Journal, and Gynecologic Oncologist at Tufts Medical Center, discusses different prevention methods in ovarian cancer.
Transcript
What has your research shown about different methods to prevent ovarian cancer?
[My] presentation [was] about ovary cancer and the current updates. It is the case that ovary cancer happens in about 1 and 70 women in their lifetime. There's people that are at higher genetic risk for that, but really it's been a disappointing number of decades trying to identify a screening test. So, part of the presentation is just kind of presenting the data that's out there, showing that it's not all that helpful.
There are some methods of preventing ovarian cancer such as removal of the ovary, it's called prophylactic surgery to reduce the risk. However, that comes with menopausal— early menopause and other health consequences. What has been more recently shown is that many of these "ovarian cancers" actually start in the tube, and the tube has no function other than allowing pregnancy.
So, what has tilted in the last couple of years— and the ACOG practice bulletins sort of magnify– the recommendation to remove the tube at the time of GYN surgery or instead of tubal ligation. We think that that is one of the more effective ways– and easy ways– of decreasing ovarian cancer in the United States.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
